Skip to main content

Table 1 Clinico-pathological features of lung cancer cases (N =96)

From: Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients

Group

Characteristics

Number (%)

Sex

  
 

Male

73(76.04%)

 

Female

23(23.96%)

Age

  
 

<60

54(56.25%)

 

≥60

42(43.75%)

Pack years of smoking

  
 

>40

47(48.96%)

 

20.1–40

4(4.17%)

 

0.1–20

8(8.33%)

 

0

37(38.54%)

Histology

  
 

LAC

41(42.71%)

 

LSCC

39(40.63%)

 

SCLC

11(11.46%)

 

LCLC

3(3.13%)

 

Undifferentiated

2(2.83%)

Pathologic grade

  
 

Poorly differentiated

26(27.08%)

 

Moderately differentiated

33(34.38%)

 

Well-differentiated

21(21.88%)

 

Others

16(16.67%)

Clinical staging

  
 

IB

3(3.1%)

 

IIA-IIB

53(55.3%)

 

IIIA-IIIB

25(26.04%)

 

IV

4(4.1%)

 

Unavailable

11(11.46%)

Pleural invasion

  
 

Absent

82(85.42%)

 

Present

14(14.58%)

Lymphatic invasion

  
 

Positive

55(57.29%)

 

Negative

41(42.71%)

  1. LAC, lung adenocarcinoma; LSCC, lung squamous cell carcinoma; SCLC, small cell lung cancer; LCLC, large cell lung cancer.